Exelixis Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, everyone. We'll continue with the next session. I'm Paul Choi, the SMid cap biotechnology analyst here at Goldman Sachs. And for our next session, I'm very pleased to host Exelixis. Joining us is the CEO, Mike Morrissey; and also on the line is Susan from Investor Relations.
And so as with prior sessions, with Exelixis here, what we'll do is let Mike kick it off with some introductory remarks, and then we'll go into the Q&A portion of the session. (Operator Instructions)
And so with that, Mike, I'll turn it over to you for some opening remarks, and then we'll go into the Q&A.
All right. Fantastic, Paul. Thanks again for the invite. Sorry, we couldn't do this live, as usual, down in L.A., but it's great to be on the call with you and your team today.
Before I begin, I'll remind you that I'll be making forward-looking statements today. So please see our SEC
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
